ARCHIVES

FDA Approves Inlyta Pill For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Scientists, Public Citizen Urge FDA To Ban Sale Of Obesity Drug Orlistat.

June 2, 2006

New NCI Directory

May 19, 1989

Young Elected ACS President, Von eschenback Pres.-Elect.

November 9, 2001

Ultrasound Shown to be Superior Diagnostic Compared to Mammography in Women Ages 30-39

October 26, 2012

Final Issues Of 1982

December 10, 1982

In Brief: Cancer Program Get Shot In Arm With Override Of Appropriations Vet; Carter To Leave NCI

February 6, 1976